Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 0.8405 Delayed Data As of Feb 02 |  0.00 / 0.00%Today’s Change | 0.70 Today|||52-Week Range 2.17 | -1.12% Year-to-Date |
Latest CRVS News | Press Releases
No recent news for Corvus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.84 |
| Today’s open | 0.81 |
| Day’s range | 0.80 - 0.84 |
| Volume | 1,184 |
| Average volume (3 months) | 135,969 |
| Market cap | $39.1M |
Data as of 3:53pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | -407.92% |
| Earnings growth (this year) | +20.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.40 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ELDNEledon Pharmaceutica... | -0.11 | -3.57% |
| NYMXNymox Pharmaceutical... | -0.01 | -2.22% |
| NOVNNovan Inc | 0.00 | 0.00% |
| SSKNSTRATA Skin Sciences... | +0.18 | +17.90% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$43.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
